Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28575-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- TRIM59 antibody
- Antibody type
- Polyclonal
- Description
- TRIM59 antibody (Cat. #28575-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IF, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references PLLP inhibits the progression of WT p53 gastric cancer by reducing p53 protein ubiquitination by binding to TRIM59.
TRIM59 suppresses mitochondrial-associated apoptosis to facilitate progression in papillary renal cell carcinoma via the ACAT1-cardiolipin pathway.
TRIM59-mediated ferroptosis enhances neuroblastoma development and chemosensitivity through p53 ubiquitination and degradation.
A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification.
Quan Z, Lin L, Xu F, Zhou C, Huang R, Sun K, Jiang H
The Journal of biological chemistry 2026 Apr;302(4):111341
The Journal of biological chemistry 2026 Apr;302(4):111341
TRIM59 suppresses mitochondrial-associated apoptosis to facilitate progression in papillary renal cell carcinoma via the ACAT1-cardiolipin pathway.
Weng H, Zhong J, Yang R, Han B, Kong Q, Zhang Y, Zhuang W, Wang J, Hu H, Lin X
Cell death & disease 2025 Aug 11;16(1):606
Cell death & disease 2025 Aug 11;16(1):606
TRIM59-mediated ferroptosis enhances neuroblastoma development and chemosensitivity through p53 ubiquitination and degradation.
Liu Y, Jiang N, Chen W, Zhang W, Shen X, Jia B, Chen G
Heliyon 2024 Feb 29;10(4):e26014
Heliyon 2024 Feb 29;10(4):e26014
A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification.
Liu Y, Zhu L, Ming Y, Wu Z, Zhang L, Chen Q, Qi Y
Journal of translational medicine 2023 Nov 17;21(1):821
Journal of translational medicine 2023 Nov 17;21(1):821
No comments: Submit comment
No validations: Submit validation data